Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/109662

Título:	The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
Autor/a:	Hernández Martinez Lapiscina, Elena; Fraga Pumar, Elena; Gabilondo, Iñigo; Martínez-Heras, Eloy; Torres Torres, Ruben; Ortiz Pérez, Santiago; Llufriu Duran, Sara; Tercero Uribe, Ana; Andorra, Magi; Figueras Roca, Marc; Lampert, Erika; Zubizarreta, Irati; Saiz Hinajeros, Albert; Sánchez Dalmau, Bernardo; Villoslada, Pablo
Notas:	BACKGROUND: Multiple Sclerosis (MS) is an immune-mediated disease of the Central Nervous System with two major underlying etiopathogenic processes: inflammation and neurodegeneration. The latter determines the prognosis of this disease. MS is the main cause of non-traumatic disability in middle-aged populations. FINDINGS: The MS-VisualPath Cohort was set up to study the neurodegenerative component of MS using advanced imaging techniques by focusing on analysis of the visual pathway in a middle-aged MS population in Barcelona, Spain. We started the recruitment of patients in the early phase of MS in 2010 and it remains permanently open. All patients undergo a complete neurological and ophthalmological examination including measurements of physical and disability (Expanded Disability Status Scale; Multiple Sclerosis Functional Composite and neuropsychological tests), disease activity (relapses) and visual function testing (visual acuity, color vision and visual field). The MS-VisualPath protocol also assesses the presence of anxiety and depressive symptoms (Hospital Anxiety and Depression Scale), general quality of life (SF-36) and visual quality of life (25-Item National Eye Institute Visual Function Questionnaire with the 10-Item Neuro-Ophthalmic Supplement). In addition, the imaging protocol includes both retinal (Optical Coherence Tomography and Wide-Field Fundus Imaging) and brain imaging (Magnetic Resonance Imaging). Finally, multifocal Visual Evoked Potentials are used to perform neurophysiological assessment of the visual pathway. DISCUSSION: The analysis of the visual pathway with advance imaging and electrophysilogical tools in parallel with clinical information will provide significant and new knowledge regarding neurodegeneration in MS and provide new clinical and imaging biomarkers to help monitor disease progression in these patients.
Materia(s):	-Esclerosi múltiple -Malalties neurodegeneratives -Visió -Depressió psíquica -Ansietat -Multiple sclerosis -Neurodegenerative diseases -Visión -Mental depression -Anxiety
Derechos:	cc-by (c) Hernández Martinez Lapiscina et al., 2014 http://creativecommons.org/licenses/by/3.0/es
Tipo de documento:	Artículo Artículo - Versión publicada
Editor:	BioMed Central
Compartir:

Mostrar el registro completo del ítem